Literature DB >> 16354016

Kinetic spectrophotometric method for the determination of ramipril in pharmaceutical formulations.

Nafisur Rahman1, Yasmin Ahmad, Syed Najmul Hejaz Azmi.   

Abstract

The objective of this research was to develop a kinetic spectrophotometric method for determination of ramipril in pure form and pharmaceutical formulations. The method was based on the reaction of carboxylic acid group of the drug with a mixture of potassium iodate (KIO3) and potassium iodide (KI) in aqueous medium at room temperature. The reaction is followed spectrophotometrically by measuring the increase in absorbance at 352 nm as a function of time. The initial-rate and fixed-time methods were adopted for constructing the calibration curves. Both the calibration curves were linear in the concentration range of 10.0-70.0 microg mL(-1). The detection limits were 0.02 microg mL(-1) and 0.15-microg mL(-1) for initial rate and fixed time methods, respectively. The proposed methods are validated statistically and through recovery studies. The point and interval hypothesis tests have been performed confirming that there is no significant difference between the proposed methods and the reference method. The experimental true bias of all samples is less than +/- 2%. The methods have been successfully applied to the determination of ramipril in tablets and capsules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16354016      PMCID: PMC2750402          DOI: 10.1208/pt060368

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  7 in total

1.  Spectrophotometric assay for chloramphenicol and some derivatives in the pure form and in formulations.

Authors:  B Morelli
Journal:  J Pharm Biomed Anal       Date:  1987       Impact factor: 3.935

2.  "Zero-crossing" derivative spectrophotometric determination of mixtures of cephapirin sodium and cefuroxime sodium in pure form and in injections.

Authors:  B Morelli
Journal:  Analyst       Date:  1988-07       Impact factor: 4.616

3.  Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules.

Authors:  B L Hogan; M Williams; A Idiculla; T Veysoglu; E Parente
Journal:  J Pharm Biomed Anal       Date:  2000-09       Impact factor: 3.935

4.  Use of 7-fluoro-4-nitrobenzo-2-oxo-1,3-diazole (NBD-F) for the determination of ramipril in tablets and spiked human plasma.

Authors:  A A Al-Majed; J Al-Zehouri
Journal:  Farmaco       Date:  2001-04

5.  Spectrophotometric and AAS determination of ramipril and enalapril through ternary complex formation.

Authors:  Magda M Ayad; Abdalla A Shalaby; Hisham E Abdellatef; Mervat M Hosny
Journal:  J Pharm Biomed Anal       Date:  2002-04-15       Impact factor: 3.935

Review 6.  Ramipril: a review of its use in the prevention of cardiovascular outcomes.

Authors:  Gregory T Warner; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Spectrophotometric and atomic absorption spectrometric determination of ramipril and perindopril through ternary complex formation with eosin and Cu(II).

Authors:  H E Abdellatef; M M Ayad; E A Taha
Journal:  J Pharm Biomed Anal       Date:  1999-01       Impact factor: 3.935

  7 in total
  1 in total

1.  Preparation, characterization, and analytical application of ramipril membrane-based ion-selective electrode.

Authors:  Hassan Arida; Mona Ahmed; Abdallah Ali
Journal:  Int J Anal Chem       Date:  2009-04-06       Impact factor: 1.885

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.